Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Scheltens

Showing results (341-350 of 953) with videos related to

Pageof 96
Sort By:
Neurology|January 2, 2015
Arterial stiffness and progression of structural brain changes: The SMART-MR studyHadassa M Jochemsen, Majon Muller, Michiel L Bots, et al.
Alzheimer'S Research & Therapy|September 21, 2016
Drug development in Alzheimer's disease: the path to 2025Jeffrey Cummings, Paul S Aisen, Bruno DuBois, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 28, 2021
Early life involvement in C9orf72 repeat expansion carriersFlora Gossink, Annemiek Dols, Max L Stek, et al.
Neurobiology of Aging|October 18, 2017
Gray matter networks and clinical progression in subjects with predementia Alzheimer's diseaseBetty M Tijms, Mara Ten Kate, Alida A Gouw, et al.
Brain : a Journal of Neurology|March 20, 2009
The clinical profile of right temporal lobe atrophyDennis Chan, Valerie Anderson, Yolande Pijnenburg, et al.
Journal of Alzheimer'S Disease : JAD|April 15, 2015
Correcting for the Absence of a Gold Standard Improves Diagnostic Accuracy of Biomarkers in Alzheimer's DiseaseEls Coart, Leandro García Barrado, Flora H Duits, et al.
European Radiology|August 2, 2011
Visual assessment of posterior atrophy development of a MRI rating scaleEsther L G E Koedam, Manja Lehmann, Wiesje M van der Flier, et al.
Journal of Alzheimer'S Disease : JAD|January 12, 2012
Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's diseaseIneke A van Rossum, Pieter Jelle Visser, Dirk L Knol, et al.
Journal of Alzheimer'S Disease : JAD|August 23, 2017
Current Approaches and Clinician Attitudes to the Use of Cerebrospinal Fluid Biomarkers in Diagnostic Evaluation of Dementia in EuropeAnne-Marie Miller, Mircea Balasa, Kaj Blennow, et al.
BMC Neuroscience|July 26, 2012
Disturbed oscillatory brain dynamics in subcortical ischemic vascular dementiaElisabeth C W van Straaten, Willem de Haan, Hanneke de Waal, et al.
Pageof 96

Showing results (341-350 of 953) with videos related to

Sort By:
Pageof 96
Neurology|January 2, 2015
Arterial stiffness and progression of structural brain changes: The SMART-MR studyHadassa M Jochemsen, Majon Muller, Michiel L Bots, et al.
Alzheimer'S Research & Therapy|September 21, 2016
Drug development in Alzheimer's disease: the path to 2025Jeffrey Cummings, Paul S Aisen, Bruno DuBois, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 28, 2021
Early life involvement in C9orf72 repeat expansion carriersFlora Gossink, Annemiek Dols, Max L Stek, et al.
Neurobiology of Aging|October 18, 2017
Gray matter networks and clinical progression in subjects with predementia Alzheimer's diseaseBetty M Tijms, Mara Ten Kate, Alida A Gouw, et al.
Brain : a Journal of Neurology|March 20, 2009
The clinical profile of right temporal lobe atrophyDennis Chan, Valerie Anderson, Yolande Pijnenburg, et al.
Journal of Alzheimer'S Disease : JAD|April 15, 2015
Correcting for the Absence of a Gold Standard Improves Diagnostic Accuracy of Biomarkers in Alzheimer's DiseaseEls Coart, Leandro García Barrado, Flora H Duits, et al.
European Radiology|August 2, 2011
Visual assessment of posterior atrophy development of a MRI rating scaleEsther L G E Koedam, Manja Lehmann, Wiesje M van der Flier, et al.
Journal of Alzheimer'S Disease : JAD|January 12, 2012
Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's diseaseIneke A van Rossum, Pieter Jelle Visser, Dirk L Knol, et al.
Journal of Alzheimer'S Disease : JAD|August 23, 2017
Current Approaches and Clinician Attitudes to the Use of Cerebrospinal Fluid Biomarkers in Diagnostic Evaluation of Dementia in EuropeAnne-Marie Miller, Mircea Balasa, Kaj Blennow, et al.
BMC Neuroscience|July 26, 2012
Disturbed oscillatory brain dynamics in subcortical ischemic vascular dementiaElisabeth C W van Straaten, Willem de Haan, Hanneke de Waal, et al.
Pageof 96